Arena Pharmaceutical Inc. (ARNA) Has Surged To A New High On Study Results

Arena Pharmaceutical Inc. (ARNA) announced after the bell Monday that its Phase 2 study of Ralinepag demonstrated a statistically significant absolute change from baseline in pulmonary vascular resistance compared to placebo in patients with pulmonary arterial hypertension.

from RTT - Hot Stocks http://ift.tt/2t0oIry
via IFTTT